United States

Zoetis Launches New Healthcare Program to Benefit Retired Military and Police Dogs

RIMADYL K-9 Courage Program™ provides medical assistance for dogs who served us

ORLANDO, FLA., Jan. 20, 2015 — Zoetis, the leading animal health company, today announced the RIMADYL K-9 Courage Program, a new program to provide veterinary medical support for retired military and police dogs.

The RIMADYL K-9 Courage Program will help with annual healthcare costs for as many as 500 retired military and police dogs. Each recipient will receive $300 on a debit card annually that can be used for services offered at their veterinary clinic such as wellness exams, vaccinations or grooming. The program is sponsored by Zoetis’ product RIMADYL® (carprofen), the most prescribed canine nonsteroidal anti-inflammatory drug (NSAID). A diagnosis of osteoarthritis is not required for participation in the program.

Zoetis also has joined with The Sage Foundation for Dogs Who Serve and the National Police Dog Foundation (NPDF) to help spread the news about the RIMADYL K-9 Courage Program and verify applicants. The company is donating an additional $10,000 to both of these partner organizations to support their general work for service dogs. Zoetis’ overall contribution for the healthcare costs of the retired dogs and the donations to the partner organizations will total up to $170,000.

Steve Leder, Senior Vice President, U.S. Companion Animals, Channel and Diagnostics, for Zoetis, presented a check to Diane Whetsel, Board Chair of The Sage Foundation for Dogs Who Serve, during a launch event on Tuesday, January 20 at the North American Veterinary Conference (NAVC) in Orlando. NPDF will be recognized at a ceremony to be held during the Western Veterinary Conference (WVC) on Tuesday, February 17 in Las Vegas, Nevada.

“Military and Contract Working Dogs (MWDs and CWDs) have saved countless lives by detecting explosive devices, locating weapons caches and alerting to enemy locations in war zones around the world,” Whetsel said. “Yet, when their service is no longer needed, their future becomes uncertain. Unlike human soldiers, these canine heroes receive no retirement benefits or health insurance. The Sage Foundation for Dogs is excited to partner with Zoetis to support healthcare for these valiant dogs.”

“The relationship between military and police officers and their canine partners is a prime example of the human-animal bond in action,” said J. Michael McFarland, DVM, DABVP, Group Director of Companion Animal Veterinary Operations, for Zoetis. “These dogs have risked their lives and served courageously to help keep us safe at home and overseas. We are pleased to help support their veterinary care so these brave dogs can remain comfortable in their retirement years.”

For more information about the how to apply for the RIMADYL K-9 Courage Program or how to help these special dogs, go to www.rimadylk9courage.com.

Cpl. Matthew Foster and Sgt. Mick

After returning from active duty in Afghanistan, Cpl. Matthew Foster, United States Marine Corps, never gave up on his goal to adopt his explosives detection dog, Sgt. Mick, a black Labrador retriever. Now honorably discharged and living with Mick in Aurora, Colorado, Cpl. Foster understands the value of programs such as RIMADYL K-9 Courage for retired military dogs such as Mick and for their human partners.

“I know firsthand the wear and tear on these dogs while they are in service, and having a program to help offset their medical needs after retirement is very useful,” he said. “After what you go through with your dog in the military and then to adopt them afterward, you wouldn’t want to say goodbye to your partner because you couldn’t afford to take care of him.”

About RIMADYL

RIMADYL is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. RIMADYL pioneered today’s standards of canine pain management 20 years ago and remains the No. 1 NSAID prescribed by veterinarians. RIMADYL is the most trusted NSAID in terms of overall value and support with more than 24 million dogs treated. Studies have shown that continuous long-term RIMADYL treatment is safe and provides progressive improvement in pain and mobility for dogs with osteoarthritis.1,2

IMPORTANT SAFETY INFORMATION

As a class, NSAIDS may be associated with gastrointestinal, kidney and liver side effects. These are usually mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including RIMADYL. Use with other NSAIDS or corticosteroids should be avoided. For more safety information on see the Full Prescribing Information.

About The Sage Foundation for Dogs Who Serve

The mission of The Sage Foundation for Dogs Who Serve is to promote the welfare of dogs who have faithfully served—often in harm’s way—in wars, police work, crime prevention and rescue efforts. The Sage Foundation for Dogs Who Serve provides medical funding through donations and strives to educate the public about the value of these four-legged soldiers once their tours of duty are complete. For more information, go to http://sagefoundationfordogs.org/.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenues of $4.6 billion.

With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com.

1 Innes JF, Clayton J, Lascelles BD. Review of the safety and efficacy of long-term NSAID use in treatment of canine osteoarthritis. Vet Rec. 2010;166(8): 226-30.
2Autefage A, Gossellin J. Efficacy and safety of long-term oral administration of carprofen in the treatment of osteoarthritis in dogs. Revue Med Vet. 2007;158(3): 119-127.

For Further Information, Contact:

Media Contacts:
Colleen White
Zoetis
908-666-5050
colleen.white@zoetis.com

Julie Lux
archer>malmo
901-500-7063
jlux@archermalmo.com